RPG Life Sciences Limited Market Cap ($452.45 Million)
Market Cap & Net Worth: RPG Life Sciences Limited (RPGLIFE)
RPG Life Sciences Limited market cap. RPG Life Sciences Limited (NSE:RPGLIFE) has a market capitalization of $452.45 Million (Rs41.84 Billion) as of November 4, 2026. Listed on the NSE stock exchange, this India-based company holds position #12426 globally and #619 in its home market, demonstrating a -8.40% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying RPG Life Sciences Limited's stock price Rs2529.60 by its total outstanding shares 16539015 (16.54 Million). Also see RPGLIFE cash flow conversion for how efficiently the company converts equity into cash flow.
RPG Life Sciences Limited Market Cap History (2015–2026)
RPG Life Sciences Limited market cap history from 2015 to 2026. Data shows growth from $48.52 Million to $452.45 Million (26.91% CAGR). Check RPGLIFE stock price and chart for real-time trading data and today's change.
RPG Life Sciences Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how RPG Life Sciences Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore RPG Life Sciences Limited annual equity growth to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.06x
RPG Life Sciences Limited's market cap is 0.06 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.39x
RPG Life Sciences Limited's market cap is 0.39 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $77.99 Million | $3.06 Billion | $204.60 Million | 0.03x | 0.38x |
| 2018 | $38.79 Million | $3.37 Billion | $134.50 Million | 0.01x | 0.29x |
| 2019 | $51.35 Million | $3.24 Billion | $108.10 Million | 0.02x | 0.48x |
| 2020 | $62.63 Million | $3.69 Billion | $290.10 Million | 0.02x | 0.22x |
| 2021 | $106.37 Million | $3.83 Billion | $400.00 Million | 0.03x | 0.27x |
| 2022 | $148.20 Million | $4.37 Billion | $514.80 Million | 0.03x | 0.29x |
| 2023 | $236.56 Million | $5.09 Billion | $676.40 Million | 0.05x | 0.35x |
| 2024 | $390.72 Million | $5.77 Billion | $876.60 Million | 0.07x | 0.45x |
| 2025 | $415.37 Million | $6.53 Billion | $1.83 Billion | 0.06x | 0.23x |
| 2026 | $452.45 Million | $7.08 Billion | $1.15 Billion | 0.06x | 0.39x |
Competitor Companies of RPGLIFE by Market Capitalization
Companies near RPG Life Sciences Limited in the global market cap rankings as of November 4, 2026. Also see RPG Life Sciences Limited asset portfolio for a full breakdown of the balance sheet.
Key companies related to RPG Life Sciences Limited by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #509 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #534 globally with a market cap of $50.42 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #580 globally with a market cap of $46.03 Billion USD ( CN¥314.55 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #618 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #509 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #534 | GALDERMA GROUP AG | NYSE:GALDY | $50.42 Billion | $45.90 |
| #580 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $46.03 Billion | CN¥49.31 |
| #618 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €18.50 |
Market Capitalization of RPG Life Sciences Limited (2015–2026)
Market capitalization of RPG Life Sciences Limited from 2015 to today. Between 2015 and today, RPG Life Sciences Limited's market cap moved from $48.52 Million to $ 452.45 Million, with a yearly change of 26.91%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Rs452.45 Million | +8.93% |
| 2025 | Rs415.37 Million | +6.31% |
| 2024 | Rs390.72 Million | +65.17% |
| 2023 | Rs236.56 Million | +59.63% |
| 2022 | Rs148.20 Million | +39.32% |
| 2021 | Rs106.37 Million | +69.85% |
| 2020 | Rs62.63 Million | +21.97% |
| 2019 | Rs51.35 Million | +32.37% |
| 2018 | Rs38.79 Million | -50.26% |
| 2017 | Rs77.99 Million | +0.98% |
| 2016 | Rs77.23 Million | +59.18% |
| 2015 | Rs48.52 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 4th, 2026 the market cap of RPG Life Sciences Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $452.45 Million USD |
| MoneyControl | $452.45 Million USD |
| MarketWatch | $452.45 Million USD |
| marketcap.company | $452.45 Million USD |
| Reuters | $452.45 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About RPG Life Sciences Limited
RPG Life Sciences Limited, an integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic, and synthetic active pharmaceutical ingredients (APIs) in India and internationally. The company offers synthetic APIs in various therapeutic categories, including immunosuppressants, anti-psychotic, anti-anginal, anthelmintics, anti-convulsant, anti-spasmodic, etc. … Read more